J. Alcudia

Regulation of lysyl oxidase in vascular cells: lysyl oxidase as a new player in cardiovascular diseases.

L. Badimón, J. Martínez-González, C. Rodríguez, 2008, Cardiovascular research.

Hypoxia-induced ROS signaling is required for LOX up-regulation in endothelial cells.

V. Cachofeiro, M. Orriols, J. Martínez-González, 2011, Frontiers in bioscience.

Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin

E. Rankin, A. Giaccia, K. Mohammad, 2015, Genes & development.

Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.

L. Badimón, J. Martínez-González, C. Rodríguez, 2009, Cardiovascular research.

Lysyl oxidase (LOX) down-regulation by TNFα: A new mechanism underlying TNFα-induced endothelial dysfunction

L. Badimón, M. Navarro, J. Martínez-González, 2008 .

Engineered Ovarian Cancer Cell Lines for Validation of CAR T Cell Function

H. Javitz, Puja Patel, L. Sambucetti, 2020, Advanced biosystems.

Lysyl oxidase (LOX) down-regulation by TNFalpha: a new mechanism underlying TNFalpha-induced endothelial dysfunction.

L. Badimón, M. Navarro, J. Martínez-González, 2008, Atherosclerosis.

A compact synthetic pathway rewires cancer signaling to therapeutic effector release

Michael Z. Lin, J. Ferrell, B. Bajar, 2019, Science.

Lysyl oxidase and endothelial dysfunction: mechanisms of lysyl oxidase down-regulation by pro-inflammatory cytokines.

L. Badimón, J. Martínez-González, M. González-Díez, 2008, Frontiers in bioscience : a journal and virtual library.